Financials

  • Market Capitalization 45.73 M
  • Employee 115
  • Founded 1998
  • CEO N/A
  • Website www.celularity.com
  • Headquarter Delaware, United States
  • FIGI BBG00P2RTT34
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-0.31
Relación precio/flujo de caja
1.07

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
4258
HYPD
Hyperion DeFi, Inc. - Common Stock
3.26 USD-9.94%-4.12%+24.90%-45.21%50.66 M USD
4282
TCRX
TScan Therapeutics, Inc. - Common Stock
0.75 USD0.00%-5.06%-3.85%-58.33%47.63 M USD
4295
HOWL
Werewolf Therapeutics, Inc. - Common Stock
0.94 USD-3.09%+10.59%+88.00%-27.69%45.68 M USD
4301
MGX
Metagenomi Therapeutics, Inc. - Common Stock
1.19 USD-1.65%-4.80%-1.65%-17.36%44.95 M USD

Noticias